Development of a point-of-care field test for Tasmanian devil facial tumour disease
Royal Society Open Science · 04.11.2026 · 13 (11)
DOI: 10.1098/rsos.260028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Royal Society Open Science, online erschienen am 11.11.2026. Verfasst von Anuk Kruawan und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Health and Medicine, University of Tasmania Menzies Institute for Medical Research, Hobart, Australia. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ARC, Animal Control Technologies Australia, Department of Natural Resources and the Environment Tasmania.
Abstract (Originalsprache)
The Tasmanian devil (Sarcophilus harrisii) population has undergone a major decline in the wild owing to the epidemics of two transmissible cancers known as devil facial tumour 1 (DFT1) and devil facial tumour 2 (DFT2). Understanding the distribution and prevalence of DFT1 and DFT2 is challenging as they can only be detected in field conditions when tumours are large enough to be visually observed. This impedes our ability to understand how the devil population is evolving in response to the tumours. PCR-based diagnostics are available, but the technique is not field-applicable. To overcome these hurdles, we developed an ultrasensitive and field-deployable rapid diagnostic tool. We used a technique called specific high-sensitivity enzymatic reporter unlocking (SHERLOCK), which combines an isothermal nucleic acid amplification step with CRISPR-based recognition and activation of reporter probes to indicate target sequence detection. This system requires only portable laboratory equipment, making it more amenable to field conditions. The results showed that our test can detect DFT1 and DFT2 DNA within the attomolar range. We then confirmed that the test can detect DFT1 in the field using non-invasive swab samples. The SHERLOCK test can be used for more active monitoring and management approaches that are not currently possible.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Health and Medicine, University of Tasmania Menzies Institute for Medical Research, Hobart, Australia.
- Tasmanian School of Medicine, University of Tasmania, Hobart, Australia.
ORCID-Profile: Anuk Kruawan, Chrissie E B Ong, Kirsten A Fairfax, Andy Flies
Förderung
- ARC
- Animal Control Technologies Australia
- Department of Natural Resources and the Environment Tasmania
- Tasmanian Nature Conservation Fund
- Ceva Wildlife Research Fund
- Select Foundation Senior Research Fellowship
- Menzies Institute for Medical Research
- Tasmanian Devil Research Grant
Zitieren
APA
Kruawan, A., Kc, R., Gell, D. A., Darby, J. M., Zhu, W., Ong, C. E. B., Fairfax, K. A., & Flies, A. (2026). Development of a point-of-care field test for Tasmanian devil facial tumour disease. Royal Society Open Science, 13(11). https://doi.org/10.1098/rsos.260028
Vancouver
Kruawan A, Kc R, Gell DA, Darby JM, Zhu W, Ong CEB, et al. Development of a point-of-care field test for Tasmanian devil facial tumour disease. Royal Society Open Science. 2026;13(11). doi:10.1098/rsos.260028
BibTeX
@article{Kruawan2026,
author = {Kruawan, Anuk and Kc, Rajendra and Gell, David A and Darby, Jocelyn M and Zhu, Weizhen and Ong, Chrissie E B and Fairfax, Kirsten A and Flies, Andy},
title = {Development of a point-of-care field test for Tasmanian devil facial tumour disease},
journal = {Royal Society Open Science},
year = {2026},
volume = {13},
number = {11},
doi = {10.1098/rsos.260028}
}
EUVIMED